The FII has announced a new investment worth a total of 5,5 million euros divided into various tranches for the purchase of a minority stake in the share capital of Labomar Srl, a company in the province of Treviso specialized in research and development and in the production of food supplements, health and dietetic products.
Labomar was founded in 199 by a pharmacist, Walter Bertin who still holds the majority share of the capital, since 2004 the current technical director Carmen Frare has also entered the capital; employs a total of 110 employees producing a turnover of 20 million euros.
One of Labomar's strengths is the research and development sector, especially in relation to the development of "new delivery systems" aimed at improving the effectiveness of the products. The R&D function accounts for about 7% of turnover, a percentage definitely above the average for Italian companies.
The Fund will intervene to allow a better integration of the supply chain for the control of raw materials, to support the increase in production capacity and commercial internationalization and finally to further increase the research and development function by promoting collaborations with universities of primary importance
“The Fondo Italiano's mission, that is to make companies grow by supporting good development programs and becoming a true partner, was the lever that prompted us to open up our capital to this important investor,” said Walter Bertin, CEO of Labomar. “The common objective is to make the company grow in a conscious and competitive manner, in relation to the Italian and international market, with particular attention to young people and Research and Development, which has always been the beating heart of Labomar. Through this contribution, Labomar will be able to anticipate investments already planned in the next 5 years, with the ambitious goal of increasing the already good growth performance that has accompanied the company for at least 8 years".
The complete press release is available in the attachment
Attachments: Press Release FII-Labomar.pdf
